by Tara Fernandez | Oct 17, 2019
RNA-based vaccines have been heralded as a new molecular weapon in the arsenal against cancer and infections. Five years ago, they were thrust into the spotlight following a $52 million investment by the Bill and Melinda Gates Foundation to CureVac, a...
by Stacey Johnson | Oct 26, 2018
It’s heartbreaking to watch this February 2018 video of Jonathan Pitre, the Canadian teen with epidermolysis bullosa (EB), who advocated for patients and fought so hard to be rid of his disease, and sadly died two months after the video below was published. He was the...
by Stacey Johnson | Sep 28, 2018
September is National Blood Cancer Awareness Month. “Few people know that many of today’s fundamental treatments for various cancers, like chemotherapy, began with blood cancer research,” explains Alicia Talarico, President, Leukemia & Lymphoma...
by Sowmya Viswanathan | Jun 26, 2018
Debe Griffin, MSc, ASQ CPGP, has over 20 years of experience in the cell therapy field, both in bench positions and in leadership. Her primary interests are process improvement, quality assurance and regulatory affairs. She is a consultant with FACT Consulting...
by Jovana Drinjakovic | Jun 15, 2018
Plagued by failures of early human studies from the 1990s, including the death of a patient, gene therapy is making a comeback with promising results. And it has a tiny virus to thank. After the first 2012 European gene therapy approval for a liver disease, and last...
Comments